Literature DB >> 15239081

Liver injury in the setting of steatosis: crosstalk between adipokine and cytokine.

Mark J Czaja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15239081     DOI： 10.1002/hep.20328

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.

Authors:  Mary E Rinella; M Shaddab Siddiqui; Konstantina Gardikiotes; Jeanne Gottstein; Marc Elias; Richard M Green
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

3.  Genetic polymorphisms in non-alcoholic fatty liver disease: clues to pathogenesis and disease progression.

Authors:  Marko Duvnjak; Neven Barsić; Vedran Tomasić; Ivan Lerotić
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

4.  Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.

Authors:  Lili Yang; Calivarathan Latchoumycandane; Megan R McMullen; Brian T Pratt; Renliang Zhang; Bettina G Papouchado; Laura E Nagy; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

5.  Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis.

Authors:  Markus Neumeier; Claus Hellerbrand; Erwin Gäbele; Roland Buettner; Cornelius Bollheimer; Johanna Weigert; Andreas Schäffler; Thomas S Weiss; Monika Lichtenauer; Jurgen Schölmerich; Christa Buechler
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

6.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa.

Authors:  Hiu-Fai Fong; Amy D Divasta; Diane Difabio; Julie Ringelheim; Maureen M Jonas; Catherine M Gordon
Journal:  J Pediatr       Date:  2008-03-19       Impact factor: 4.406

8.  High-sensitivity C-reactive protein and liver enzymes in individuals with Metabolic Syndrome in Talca, Chile.

Authors:  E Leiva; V Mujica; I Palomo; R Orrego; L Guzmán; S Núñez; R Moore-Carrasco; G Icaza; N Díaz
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

9.  Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  M S Mirza
Journal:  ISRN Gastroenterol       Date:  2011-08-28

10.  Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.

Authors:  Luis A Videla; Paulina Pettinelli
Journal:  PPAR Res       Date:  2012-12-09       Impact factor: 4.964
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.